根据年龄分层对阿齐思罗米的药监测:FAERS数据库中的多方法信号检测分析
Zhenpo Zhang1, Jiangxiong Li2, Jingping Zheng1
1College of Pharmacy, Jinan University, Guangzhou, People's Republic of China.
Journal of pharmaceutical policy and practice
|July 10, 2025
概括
亚兹罗米辛的安全性因年龄而异,儿童患有皮肤和精神问题,老年人面临心脏风险. 仔细监测和遵守指导方针对于安全使用阿齐思罗米至关重要.
科学领域:
- 药监和药物安全 药监和药物安全
- 临床药理学 临床药理学
- 抗生素研究 抗生素研究
背景情况:
- 作为一种常见的宏类抗生素,阿齐思罗米 (azithromycin) 出现了与滥用和特定年龄的不良药反应 (ADRs) 相关的安全问题.
- 了解年龄分层的安全概况对于优化阿齐思罗米辛的使用至关重要.
研究的目的:
- 描述阿齐思罗米的年龄分层安全概况.
- 为了在不同年龄组中识别与阿齐思罗米相关的特定不良药物反应 (ADRs).
主要方法:
- 利用了FDA不良事件报告系统 (FAERS) 的药监数据,用于在Mycoplasma pneumoniae肺炎治疗中使用阿兹罗密辛 (2004-2024年).
- 雇员不成比例分析检测四个年龄层的安全信号:0-17,18-44,45-64和≥65岁.
主要成果:
- 在7,496份不良事件 (AE) 报告中,确定了与年龄相关的重大风险.
- 儿科患者 (0-17岁) 显示皮肤/过敏反应增加和未标记的精神信号.
- 成年人 (18-44岁) 面临与怀孕相关的风险,而老年患者 (≥65岁) 则表现出心脏风险增加,通常与非标签COVID-19使用有关.
结论:
- 在不同年龄组中,阿兹罗米辛的安全性概况显著不同,因此需要对年龄特定的监测.
- 儿童易患皮肤病和神经精神病风险;老年人易患心脏并发症.
- 遵守标签上的适应症,年龄特定的监测,避免非标签使用对于减轻阿齐思罗米辛的副作用至关重要.
更多相关视频
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.0K
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
13.2K
相关概念视频
01:19Pharmacovigilance
999
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
999
01:12Analysis of Population Pharmacokinetic Data
394
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
394